Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Examining the Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures: a Randomized Control Trial.

NCT01727843 is registered in ClinicalTrials.gov with Dr. Jeff Yach as lead sponsor.

NCT NCT01727843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01727843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Examining the Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures: a Randomized Control Trial.
Lead sponsor
Dr. Jeff Yach
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2013
Completion date
November 3, 2017
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoral neck fracture